1290 Essex Small Cap Growth I holds a quantitatively derived Gold Morningstar Medalist Rating. The rating reflects that it has scored particularly well on factors Morningstar research associates with future outperformance relative to category peers.
1290 Essex Small Cap Growth Fund Class I ESCJX
- NAV / 1-Day Return 18.84 / +1.08 %
- Total Assets 116.5M
-
Adj. Expense Ratio
0.880%
- Expense Ratio 0.880%
- Distribution Fee Level Below Average
- Share Class Type Institutional
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 1M
- Status Open
- TTM Yield 0.00
- Turnover 55%
USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 3:50 AM GMT+0
Morningstar’s Analysis ESCJX
Will ESCJX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 19.3
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Kiniksa Pharmaceuticals International PLC Class A | 2.74 | 3M | Healthcare |
Adaptive Biotechnologies Corp | 2.45 | 3M | Healthcare |
JPMorgan Prime Money Market IM | 2.33 | 3M | Cash and Equivalents |
CECO Environmental Corp | 2.24 | 3M | Industrials |
Travere Therapeutics Inc Ordinary Shares | 1.97 | 2M | Healthcare |
Leonardo DRS Inc | 1.96 | 2M | Industrials |
Oceaneering International Inc | 1.72 | 2M | Energy |
BrainsWay Ltd ADR | 1.72 | 2M | Healthcare |
Tower Semiconductor Ltd | 1.57 | 2M | Technology |
Lincoln Educational Services Corp | 1.52 | 2M | Consumer Defensive |